Avalyn Pharma Inc. (AVLN) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$0
Day's range
$0

Avalyn Pharma Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/13/2026 5.84 M $192.10 M   100.00% 13.16%
NOVO HOLDINGS A/S 08/14/2026 3.88 M $127.84 M   100.00% 8.76%
SR ONE CAPITAL MANAGEMENT, LP 08/12/2026 3.31 M $108.92 M   100.00% 7.46%
PERCEPTIVE ADVISORS LLC 08/14/2026 2.68 M $88.07 M   100.00% 6.03%
SUVRETTA CAPITAL MANAGEMENT, LLC 08/14/2026 2.50 M $82.40 M   100.00% 5.65%
NVP ASSOCIATES, LLC 08/07/2026 2.27 M $74.68 M   100.00% 5.12%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 2.20 M $72.49 M   100.00% 4.97%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 1.74 M $57.12 M   100.00% 3.91%
CATALIO CAPITAL MANAGEMENT, LP 08/14/2026 1.68 M $55.17 M   100.00% 3.78%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 1.60 M $52.76 M   100.00% 3.62%
EVENTIDE ASSET MANAGEMENT, LLC 08/14/2026 1.38 M $45.28 M   100.00% 3.10%
BELLEVUE GROUP AG 08/14/2026 1.35 M $44.44 M   100.00% 3.05%
BLACKROCK, INC. 08/07/2026 977.26 K $32.17 M   100.00% 2.20%
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC 08/13/2026 966.79 K $31.83 M   100.00% 2.18%
CITADEL ADVISORS LLC 09/02/2026 959.10 K $31.57 M   100.00% 2.16%
ANDERA PARTNERS 07/22/2026 929.82 K $30.61 M   100.00% 2.10%
JENNISON ASSOCIATES LLC 08/03/2026 812.75 K $26.76 M   100.00% 1.83%
BRAIDWELL LP 08/14/2026 801.40 K $26.38 M   100.00% 1.81%
TPG GP A, LLC 08/14/2026 773.07 K $25.45 M   100.00% 1.74%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 739.77 K $24.35 M   100.00% 1.67%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 08/14/2026 731.00 K $24.06 M   100.00% 1.65%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 662.92 K $21.82 M   100.00% 1.50%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 434.65 K $14.31 M   100.00% 0.98%
SOLEUS CAPITAL MANAGEMENT, L.P. 08/11/2026 419.00 K $13.79 M   100.00% 0.95%
INFINITUM ASSET MANAGEMENT, LLC 08/14/2026 411.38 K $13.54 M   100.00% 0.93%
BAKER BROS. ADVISORS LP 08/14/2026 350.00 K $11.52 M   100.00% 0.79%
FRANKLIN RESOURCES INC 08/13/2026 331.68 K $10.92 M   100.00% 0.75%
SILVERARC CAPITAL MANAGEMENT, LLC 08/13/2026 330.49 K $10.88 M   100.00% 0.75%
GOLDMAN SACHS GROUP INC 08/14/2026 283.85 K $9.34 M   100.00% 0.64%
FEDERATED HERMES, INC. 08/12/2026 160.00 K $5.27 M   100.00% 0.36%
WOODLINE PARTNERS LP 08/14/2026 151.00 K $4.97 M   100.00% 0.34%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 146.99 K $4.84 M   100.00% 0.33%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 146.99 K $4.84 M   100.00% 0.33%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 146.45 K $4.82 M   100.00% 0.33%
NORTHERN TRUST CORP 08/13/2026 136.39 K $4.49 M   100.00% 0.31%
STEMPOINT CAPITAL LP 08/14/2026 118.00 K $3.88 M   100.00% 0.27%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 117.34 K $3.86 M   100.00% 0.26%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 116.76 K $3.84 M   100.00% 0.26%
ACUTA CAPITAL PARTNERS, LLC 08/14/2026 115.00 K $3.79 M   100.00% 0.26%
BURKEHILL GLOBAL MANAGEMENT, LP 08/14/2026 115.00 K $3.79 M   100.00% 0.26%
MOORE CAPITAL MANAGEMENT, LP 08/14/2026 110.45 K $3.64 M   100.00% 0.25%
BLACKSTONE INC. 08/14/2026 97.99 K $3.23 M   100.00% 0.22%
TD ASSET MANAGEMENT INC 08/04/2026 94.64 K $3.12 M   100.00% 0.21%
SEVEN GRAND MANAGERS, LLC 08/14/2026 75.00 K $2.47 M   100.00% 0.17%
GHISALLO CAPITAL MANAGEMENT LLC 08/14/2026 70.00 K $2.30 M   100.00% 0.16%
ATOM INVESTORS LP 08/14/2026 68.25 K $2.25 M   100.00% 0.15%
ABRDN PLC 07/31/2026 67.17 K $2.21 M   100.00% 0.15%
ZIMMER PARTNERS, LP 08/14/2026 62.50 K $2.06 M   100.00% 0.14%
AVIDITY PARTNERS MANAGEMENT LP 08/14/2026 60.00 K $1.98 M   100.00% 0.14%
LMR PARTNERS LLP 08/14/2026 54.32 K $1.79 M   100.00% 0.12%

Avalyn Pharma Inc. institutional Ownership - FAQ's

During the previous two years, 94 institutional investors and hedge funds held shares of Avalyn Pharma Inc.. The most heavily invested institutionals were:

FMR LLC: 5.84 M

Novo Holdings A/S: 3.88 M

SR ONE CAPITAL MANAGEMENT, LP: 3.31 M

PERCEPTIVE ADVISORS LLC: 2.68 M

SUVRETTA CAPITAL MANAGEMENT, LLC: 2.5 M

NVP Associates, LLC: 2.27 M

99.60% of Avalyn Pharma Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 44.15 M shares in the last 24 months. This purchase volume represents approximately $0 in transactions.